RxDoctor Payments DataLook up a doctor →

James Voci, MD

Neurology · Evanston, ILNPI 1366476715

Payments from drug & device makers

$344,918in general payments, 2019–2025

Across 1,289 payments — averaging $267.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$51K
  • Biogen$46K
  • Teva Pharmaceuticals USA, Inc.$40K
  • Avanir Pharmaceuticals, Inc.$36K
  • EMD Serono, Inc.$28K
  • Jazz Pharmaceuticals Inc.$25K
  • plus $119K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC138$50,775
Biogen82$46,006
Teva Pharmaceuticals USA, Inc.75$40,340
Avanir Pharmaceuticals, Inc.54$36,261
EMD Serono, Inc.81$27,608
Jazz Pharmaceuticals Inc.68$24,867
AbbVie(2 entities)72$21,889
Otsuka America Pharmaceutical, Inc.45$21,707
Sanofi57$15,432
Eisai Inc.32$15,412
Mallinckrodt Enterprises LLC12$10,378
Biohaven Pharmaceuticals, Inc.7$7,274
Eli Lilly2$5,440
UCB, Inc.100$4,288
Biohaven Pharmaceutical Holding Company Ltd.7$3,101
Novartis93$2,576
Argenx US, Inc.10$2,500
Mallinckrodt Hospital Products Inc.12$2,369
Corium, LLC6$856
Genentech USA, Inc.27$491
Lundbeck LLC37$489
Pfizer29$468
Banner Life Sciences, LLC30$378
Alnylam Pharmaceuticals Inc.14$315
Amgen(2 entities)20$300
MDD US Operations, LLC16$224
AstraZeneca(2 entities)12$207
Bristol Myers Squibb10$200
Greenwich Biosciences, Inc.4$188
SK Life Science, Inc.8$180
Acorda Therapeutics, Inc9$172
TG Therapeutics, Inc.7$133
Adamas Pharmaceuticals, Inc.6$116
Vertical Pharmaceuticals, LLC13$114
Livanova USA, Inc.4$112
ANI Pharmaceuticals, Inc.4$103
Acadia Pharmaceuticals Inc5$96
Johnson & Johnson1$96
CSL Behring5$88
Catalyst Pharmaceuticals, Inc.5$84
Akcea Therapeutics, Inc.4$81
Neurelis, Inc.3$80
Amneal Pharmaceuticals LLC4$75
Takeda Pharmaceuticals U.S.A., Inc.3$74
Sunovion Pharmaceuticals Inc.5$74
Promius Pharma LLC5$71
Scilex Pharmaceuticals Inc.4$69
Kyowa Kirin, Inc.3$67
Grifols USA, LLC3$65
Impel Pharmaceuticals Inc.3$63
Neurocrine Biosciences, Inc.3$59
Azurity Pharmaceuticals, Inc.2$50
Collegium Pharmaceutical, Inc.3$48
Supernus Pharmaceuticals, Inc.3$47
Tersera Therapeutics LLC2$45
Bausch Health US, LLC2$43
Abbott3$43
Cycle Pharmaceuticals Inc2$39
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$30
Impel Pharmaceuticals LLC2$29

How this compares

$344,918 in reported general payments places this provider in the 90th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois →

Medicare billing

Part B allowed, 2024
$115,089
Medicare patients
523
Services billed
904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Evanston

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →